Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 8,000 (estimated)
- Sponsor
- Spanish Breast Cancer Research Group · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group. Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years
Loading trial locations…